Immersive virtual reality may ease the pain and distress felt by patients with cancer, suggests a new analysis of published evidence. According to the study, published...
A novel combination prostate cancer therapy has been approved by the US Food and Drug Administration. The new treatment combines two Pfizer-produced cancer drugs, Xtandi (also...
Human papillomavirus (HPV) related throat and mouth cancers could soon be among the most common forms of the disease in adults between the ages of 45...
A new antibody has been identified that could help patients who don’t respond to current therapies for the most aggressive form of skin cancer. Researchers at...
A new artificial intelligence tool may be able to successfully identify people at risk of pancreatic cancer up to three years in advance. The breakthrough AI...
Scientists researching an ‘ancient virus’ treatment for metastatic prostate cancer have been awarded $1.7 million by the US Department for Defense. Oncology expert Charles Spruck’s laboratory...
An innovative test to help detect the early stages of oesophageal cancer, has won £3.4m in grant funding. It means more diagnostic tests can be offered...
A new drug combo has been shown to boost metastasis-free survival by 58% in prostate cancer patients at high risk of biochemical recurrence. Astellas Pharma and...
A seven-figure funding boost to further develop a prostate cancer test could help save thousands of lives, its developers say. Despite being the most common malignancy...
New findings could allow experts to improve DNA repair in body cells and target the causes of ageing and cancer development. A protein complex prevents the...
